Stair climbing was linked to a 39% lower risk of dying from cardiovascular disease, according to an analysis of more than 480 ...
Background Fluid restriction is a commonly prescribed non-pharmacological intervention in the management of heart failure (HF). However, data on its efficacy and safety are scarce. Recent randomised ...
Morning Overview on MSN
An off-the-shelf cell therapy slowed deadly Duchenne heart failure by 91% in trials
A cell therapy made from donor heart cells slowed the decline of cardiac function in boys and young men with Duchenne ...
Heart failure mortality rates are moving in the wrong direction, a new analysis reports, reversing a decline in deaths that means more people in the United States are dying of the condition today than ...
Diastolic heart failure means there’s a problem with your heart’s ability to fill with blood. It’s a type of congestive heart failure where your heart cannot work efficiently, leading to fluid ...
The threat of heart disease, and of dying from it, is rising among young women. Recent research has suggested that nearly one ...
COLUMBUS, Ga. (WRBL) — Healthcare professionals with Piedmont Columbus Regional performed their first Barostim procedure, ...
Congestive heart failure (CHF) and kidney disease share a two-way relationship. CHF reduces blood flow to the kidneys, while kidney disease can increase blood pressure and strain the heart. Treatment ...
Nonmodifiable risk factors for heart failure include being Black and African American, being the age of 65 years or older, or living with certain health conditions like diabetes. Modifiable risk ...
The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart ...
Congestive heart failure, or heart failure, causes symptoms, including a cough. A congestive heart failure cough may occur due to fluid buildup in the lungs or as a side effect of medication. A cough ...
The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally, sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results